HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An altered secretome is an early marker of the pathogenesis of CLN6 Batten disease.

Abstract
Neuronal ceroid lipofuscinoses (NCLs) are a group of inherited childhood neurodegenerative disorders. In addition to the accumulation of auto-fluorescent storage material in lysosomes, NCLs are largely characterised by region-specific neuroinflammation that can predict neuron loss. These phenotypes suggest alterations in the extracellular environment-making the secretome an area of significant interest. This study investigated the secretome in the CLN6 (ceroid-lipofuscinosis neuronal protein 6) variant of NCL. To investigate the CLN6 secretome, we co-cultured neurons and glia isolated from Cln6nclf or Cln6± mice, and utilised mass spectrometry to compare protein constituents of conditioned media. The significant changes noted in cathepsin enzymes, were investigated further via western blotting and enzyme activity assays. Viral-mediated gene therapy was used to try and rescue the wild-type phenotype and restore the secretome-both in vitro in co-cultures and in vivo in mouse plasma. In Cln6nclf cells, proteomics revealed a marked increase in catabolic and cytoskeletal-associated proteins-revealing new similarities between the pathogenic signatures of NCLs with other neurodegenerative disorders. These changes were, in part, corrected by gene therapy intervention, suggesting these proteins as candidate in vitro biomarkers. Importantly, these in vitro changes show promise for in vivo translation, with Cathepsin L (CTSL) activity reduced in both co-cultures and Cln6nclf plasma samples post gene-therapy. This work suggests the secretome plays a role in CLN6 pathogenesis and highlights its potential use as an in vitro model. Proteomic changes present a list of candidate biomarkers for monitoring disease and assessing potential therapeutics in future studies.
AuthorsHannah L Best, Alison J Clare, Kirstin O McDonald, Hollie E Wicky, Stephanie M Hughes
JournalJournal of neurochemistry (J Neurochem) Vol. 157 Issue 3 Pg. 764-780 (05 2021) ISSN: 1471-4159 [Electronic] England
PMID33368303 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 International Society for Neurochemistry.
Chemical References
  • Biomarkers
  • Cln6 protein, mouse
  • Membrane Proteins
  • Cathepsin L
  • Ctsl protein, mouse
Topics
  • Animals
  • Biomarkers
  • Cathepsin L (biosynthesis)
  • Coculture Techniques
  • Computational Biology
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation
  • Genetic Therapy
  • Male
  • Membrane Proteins (genetics)
  • Mice
  • Mice, Knockout
  • Neuroglia (metabolism)
  • Neuronal Ceroid-Lipofuscinoses (diagnosis, drug therapy, genetics)
  • Neurons (metabolism)
  • Primary Cell Culture
  • Proteomics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: